Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

McKesson
Harvard Business School
Moodys
McKinsey
Express Scripts
Boehringer Ingelheim

Last Updated: January 22, 2020

DrugPatentWatch Database Preview

Litigation Details for Leupold & Stevens, Inc. v. Lightforce USA, Inc. (D. Or. 2016)

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Leupold & Stevens, Inc. v. Lightforce USA, Inc. (D. Or. 2016)

Docket   Start Trial Date Filed 2016-08-02
Court District Court, D. Oregon Date Terminated
Cause 35:271 Patent Infringement Assigned To Marco Antonio Hernandez
Jury Demand Both Referred To
Parties LEUPOLD & STEVENS, INC.; LIGHTFORCE USA, INC.
Patents 10,066,019; 10,086,011; 10,183,012; 10,183,020; 10,184,001; 5,317,010; 6,121,021; 6,204,012; 6,242,003; 6,469,009; 8,039,009; 8,217,020; 8,269,019; 9,023,001; 9,061,003; 9,081,016; 9,109,010; 9,127,013; 9,228,018; 9,352,013; 9,446,001; 9,453,006; 9,457,020
Attorneys Brian C. Park; David A. Casimir; Elliott J. Williams; J. Christopher Carraway; Kassim M. Ferris; Nathan C. Brunette; Scott E. Davis; Todd M. Siegel
Firms Casimir Jones SC; Stoel & Rives, LLP; Stoel Rives, LLP Seattle
Link to Docket External link to docket
Small Molecule Drugs cited in Leupold & Stevens, Inc. v. Lightforce USA, Inc.
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .
Biologic Drugs cited in Leupold & Stevens, Inc. v. Lightforce USA, Inc.

Details for Leupold & Stevens, Inc. v. Lightforce USA, Inc. (D. Or. 2016)

Date Filed Document No. Description Snippet Link To Document
0000-00-00 164 13:19, 17:9, single [9] - 20:9, 61:3, 66:10, 66:19, started [1] - 11:21 27:15, 27:17, 28:21… technician [7] - 20:21, 66:10, 66:19, tie [1] - 8:11 stretch [1] - 33:15 …will be lost. This patent case is just simply -- if it 13 was one patent, maybe. You have…relevant -- and this is the '305 patent and the 10 '907 patent, because over 90 percent of the…'305 patent. 22 And the first thing we wanted to talk about on the '305 patent 23 External link to document
2019-02-01 165 laterally [3] - 86:10, 86:11 letters [1] - 96:15 labeled [1…17, 111:19, pushes [3] - 86:9, 86:10, 86:11 194:18, 194:19, 194:20, 194:25, 111…number of 6 patents, all of the patents in this case, including the '907 7 patent. 8 …about the patent infringement, wanted the patent infringement, 18 and appeared to put the patent owner … '907 patent claims are entitled to claim 15 priority back to the provisional patent application External link to document
0000-00-00 169 360:6, 362:3, 363:5, Leupold [113] - 317:5, 317:10, 330:2, Lightforce [1] - 317:6 363:10,…6] - 389:23, 410:6, 467:10, Stevens [3] - 317:5, 317:10, 337:12 …the pinch-to-turn patent, which 5 is the '408 patent; and the '068 patent, which is the ZeroLock…three Windauer 18 patents as well as the '408 patent and the '068 patent. 19 Nightforce…'408 patent. The '408 patent, for refresher, is the 4 pinch-and-turn patent that was External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Express Scripts
McKesson
Merck
Harvard Business School
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.